Viridien stock rebounds by more than 3%, boosted by Brent above $98
Supported by Brent holding above 98 dollars, Viridien ranks among the strongest gainers of the SBF 120 this Tuesday, in a Paris market that is globally declining. The session comes as Bernstein raises its price target on the stock and net short positions remain at elevated levels, two signals that warrant attention.
Bernstein raises its target to €142 amid Brent at its highest in six weeks
Bernstein raised its price target on Viridien this Tuesday from €130 to €142, while maintaining an outperform rating. At €92.25, the stock displays an implicit upside potential of nearly 54% relative to this revised target. Today's movement occurs in a favorable oil context: Brent is trading around $98.90 per barrel, driven since late August by military tensions around the Strait of Hormuz, which are disrupting crude flows in the Middle East.
Viridien, a geoscience specialist directly exposed to petroleum exploration cycles, naturally benefits from this configuration. Over the week, the stock is already gaining more than 5%, following a 3.5% rebound on Monday already supported by the same oil dynamics. On fundamentals, during the publication of Q1 2026 results on May 5th, the company confirmed its annual target for net cash flow generation of 100 million dollars, with expected seasonality similar to that of 2025.
Below the 200-day moving average despite the rebound, short positions still elevated on the stock
Despite its 3.13% gain in the session, Viridien remains below its 200-day moving average, which stands at €108.06, representing a gap of nearly 15% above the current price. The stock is nevertheless above its 20-day (€90.18) and 50-day (€85.58) moving averages, which draws an intermediate configuration: short-term momentum is positive, but the path to the 200-day moving average remains long. The RSI at 52 reflects a neutral configuration, with no overbought signal despite the recent series of rebounds. The resistance at €99.40 constitutes the next threshold to overcome to confirm the recovery.
Furthermore, according to recorded disclosures, eight funds cumulate 6.43% of capital sold short, up 1.37 points over thirty days. This elevated level indicates that a significant portion of institutional investors remain positioned against the stock, though it is not possible to know their precise motivations. This point warrants monitoring over time, especially as annual performance remains robust at +57.83%, providing favorable ground for profit-taking.
